Login to Your Account



Firms Split Ownership 50-50

Pharmathene, Theraclone Merge Pipelines in All-Stock Transaction

By Catherine Shaffer
Staff Writer

Thursday, August 1, 2013
A merger agreement between Pharmathene Inc., of Annapolis, Md., and Theraclone Sciences Inc., of Seattle, will create a combined company boasting four clinical-stage antibodies in the areas of infectious disease.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription